Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Beguin

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
Pathologie-Biologie|July 13, 2014
[Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC]S Belaiche, N Yafour, S Balcaen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Leukemia|October 1, 2010
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMTM Robin, G F Sanz, I Ionescu, et al.
Bone Marrow Transplantation|December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)P Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|February 20, 2025
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working partyL G M Daenen, L E van der Wagen, E F Bonneville, et al.
Acta Clinica Belgica|November 8, 2014
Myelofibrosis patients in Belgium: disease characteristicsT Devos, P Zachée, D Bron, et al.
Vox Sanguinis|August 31, 2002
International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantationC P Engelfriet, H W Reesink, J E Wagner, et al.
Blood|June 25, 1998
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patientsE Hellström-Lindberg, T Ahlgren, Y Beguin, et al.
Bone Marrow Transplantation|August 26, 1998
Circadian and seasonal variations of hematopoiesis in cord bloodE Baudoux, Y Beguin, G Cornu, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
Pathologie-Biologie|July 13, 2014
[Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC]S Belaiche, N Yafour, S Balcaen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Leukemia|October 1, 2010
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMTM Robin, G F Sanz, I Ionescu, et al.
Bone Marrow Transplantation|December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)P Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|February 20, 2025
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working partyL G M Daenen, L E van der Wagen, E F Bonneville, et al.
Acta Clinica Belgica|November 8, 2014
Myelofibrosis patients in Belgium: disease characteristicsT Devos, P Zachée, D Bron, et al.
Vox Sanguinis|August 31, 2002
International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantationC P Engelfriet, H W Reesink, J E Wagner, et al.
Blood|June 25, 1998
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patientsE Hellström-Lindberg, T Ahlgren, Y Beguin, et al.
Bone Marrow Transplantation|August 26, 1998
Circadian and seasonal variations of hematopoiesis in cord bloodE Baudoux, Y Beguin, G Cornu, et al.
Pageof 20